164 related articles for article (PubMed ID: 3046293)
21. Impaired skeletal muscle nutritive flow during exercise in patients with congestive heart failure: role of cardiac pump dysfunction as determined by the effect of dobutamine.
Wilson JR; Martin JL; Ferraro N
Am J Cardiol; 1984 May; 53(9):1308-15. PubMed ID: 6711433
[TBL] [Abstract][Full Text] [Related]
22. Effects of acetylsalicylic acid on peripheral hemodynamics in patients with chronic heart failure treated with angiotensin-converting enzyme inhibitors.
van Wijngaarden J; Smit AJ; de Graeff PA; van Gilst WH; van der Broek SA; van Veldhuisen DJ; Lie KI; Wesseling H
J Cardiovasc Pharmacol; 1994 Feb; 23(2):240-5. PubMed ID: 7511753
[TBL] [Abstract][Full Text] [Related]
23. [Regional blood flow in congestive cardiac failure and inhibition of angiotensin converting enzyme].
Garnier LF; François G; Raynaud PH; Brochier M
Rev Med Interne; 1986 Nov; 7(5):548-53. PubMed ID: 3027822
[TBL] [Abstract][Full Text] [Related]
24. Coronary hemodynamic effects of angiotensin inhibition by captopril and teprotide in patients with congestive heart failure.
Halperin JL; Faxon DP; Creager MA; Bass TA; Melidossian CD; Gavras H; Ryan TJ
Am J Cardiol; 1982 Nov; 50(5):967-72. PubMed ID: 6182786
[TBL] [Abstract][Full Text] [Related]
25. Effect of long-term angiotensin-converting enzyme inhibition on vascular function in patients with chronic congestive heart failure.
Jeserich M; Pape L; Just H; Hornig B; Kupfer M; Münzel T; Lohmann A; Olschewski M; Drexler H
Am J Cardiol; 1995 Nov; 76(14):1079-82. PubMed ID: 7484869
[TBL] [Abstract][Full Text] [Related]
26. Haemodynamic, neurohumoral and exercise effects of losartan vs. captopril in chronic heart failure: results of an ELITE trial substudy. Evaluation of Losartan in the Elderly.
Houghton AR; Harrison M; Cowley AJ
Eur J Heart Fail; 1999 Dec; 1(4):385-93. PubMed ID: 10937952
[TBL] [Abstract][Full Text] [Related]
27. [Ergospirometry in the evaluation of cardiovascular drugs].
Kleber FX; Doering W
Z Kardiol; 1994; 83 Suppl 3():89-96. PubMed ID: 7941678
[TBL] [Abstract][Full Text] [Related]
28. Effect of dobutamine on skeletal muscle metabolism in patients with congestive heart failure.
Mancini DM; Schwartz M; Ferraro N; Seestedt R; Chance B; Wilson JR
Am J Cardiol; 1990 May; 65(16):1121-6. PubMed ID: 2330898
[TBL] [Abstract][Full Text] [Related]
29. Effect of hydralazine on perfusion and metabolism in the leg during upright bicycle exercise in patients with heart failure.
Wilson JR; Martin JL; Ferraro N; Weber KT
Circulation; 1983 Aug; 68(2):425-32. PubMed ID: 6861318
[TBL] [Abstract][Full Text] [Related]
30. Physical training in patients with stable chronic heart failure: effects on cardiorespiratory fitness and ultrastructural abnormalities of leg muscles.
Hambrecht R; Niebauer J; Fiehn E; Kälberer B; Offner B; Hauer K; Riede U; Schlierf G; Kübler W; Schuler G
J Am Coll Cardiol; 1995 May; 25(6):1239-49. PubMed ID: 7722116
[TBL] [Abstract][Full Text] [Related]
31. Angiotensin converting enzyme inhibition, AT1 receptor inhibition, and combination therapy with pacing induced heart failure: effects on left ventricular performance and regional blood flow patterns.
Krombach RS; Clair MJ; Hendrick JW; Houck WV; Zellner JL; Kribbs SB; Whitebread S; Mukherjee R; de Gasparo M; Spinale FG
Cardiovasc Res; 1998 Jun; 38(3):631-45. PubMed ID: 9747431
[TBL] [Abstract][Full Text] [Related]
32. Blood flow distribution within skeletal muscle during exercise in the presence of chronic heart failure: effect of milrinone.
Drexler H; Faude F; Höing S; Just H
Circulation; 1987 Dec; 76(6):1344-52. PubMed ID: 3677357
[TBL] [Abstract][Full Text] [Related]
33. Sustained haemodynamic and clinical effects of captopril in long-term treatment of severe chronic congestive heart failure.
Ricci S; Zaniol P; Teglio V; Baraldi P; Mattioli G
Br J Clin Pharmacol; 1982; 14 Suppl 2(Suppl 2):209S-215S. PubMed ID: 6291564
[TBL] [Abstract][Full Text] [Related]
34. Benefits of prolonged angiotensin-converting enzyme inhibition in congestive heart failure.
Giles TD
Cardiology; 1991; 79 Suppl 1():16-21. PubMed ID: 1680559
[TBL] [Abstract][Full Text] [Related]
35. Skeletal muscle abnormalities in chronic heart failure patients: relation to exercise capacity and therapeutic implications.
Nicoletti I; Cicoira M; Zanolla L; Franceschini L; Brighetti G; Pilati M; Zardini P
Congest Heart Fail; 2003; 9(3):148-54. PubMed ID: 12826773
[TBL] [Abstract][Full Text] [Related]
36. Exercise intolerance in patients with chronic heart failure: role of impaired nutritive flow to skeletal muscle.
Wilson JR; Martin JL; Schwartz D; Ferraro N
Circulation; 1984 Jun; 69(6):1079-87. PubMed ID: 6713612
[TBL] [Abstract][Full Text] [Related]
37. [Central and regional vascular hemodynamics of milrinone in experimental heart failure: comparison with captopril and dobutamine].
Drexler H; Faude F; Winterer H; Wollschläger H; Freudenberg N; Just H
Z Kardiol; 1987 Aug; 76(8):507-13. PubMed ID: 3314215
[TBL] [Abstract][Full Text] [Related]
38. Reduced exercise tolerance in chronic heart failure and its relationship to neurohumoral factors.
Drexler H
Eur Heart J; 1991 Aug; 12 Suppl C():21-8. PubMed ID: 1680684
[TBL] [Abstract][Full Text] [Related]
39. Effect of chronic angiotensin-converting enzyme inhibition on endothelial function in patients with chronic heart failure.
Drexler H; Kurz S; Jeserich M; Münzel T; Hornig B
Am J Cardiol; 1995 Nov; 76(15):13E-18E. PubMed ID: 7484881
[TBL] [Abstract][Full Text] [Related]
40. [Pathophysiology of heart failure: peripheral vascular and muscular mechanisms].
Kiowski W
Ther Umsch; 1993 Jun; 50(6):394-400. PubMed ID: 8351668
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
